People: Synergy Pharmaceuticals Inc (SGYP.O)
5.11USD
23 May 2013
$0.06 (+1.19%)
$5.05
$5.01
$5.13
$4.91
516,973
1,016,012
$7.44
$2.98
Joslyn, Alan
Brief Biography
Dr. Alan F. Joslyn is Director of Synergy Pharmaceuticals Inc., since October 2009. Since August 2011, Dr. Joslyn has been a drug development consultant to Sentinella Pharmaceuticals. From August 2009 to August 2011 Dr. Joslyn served as the Chief Executive Officer of Edusa Pharmaceuticals, a privately held biotechnology company. From 2007 to 2009, Dr. Joslyn served as President and Chief Executive Officer of Mt. Cook Pharma and as Senior Vice President of Research & Development at Penwest Pharmaceuticals from 2004 to 2007. From 1995 to 2004, Dr. Joslyn held a number of leadership positions within Johnson & Johnson focusing on development of gastroenterology products including Propulsid®, Motilium®, Aciphex® and prucalopride. Dr. Joslyn received his B.S. in medicinal chemistry, B.A. in biology and Ph.D. in biochemical pharmacology from the State University of New York at Buffalo.
Basic Compensation
| Total Annual Compensation, | Long-Term Incentive Plans, | All Other, | Fiscal Year Total, |
|---|---|---|---|
| -- | -- | -- | -- |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
Gabriele Cerrone |
2,695,400 |
Gary Jacob |
2,695,400 |
Bernard Denoyer |
816,443 |
Kunwar Shailubhai |
534,842 |
Alan Joslyn |
-- |
Thomas Adams |
-- |

